Conference negotiators trim and rework H.660 opioid-abatement appropriations, defer most new FY28 awards

The conference committee meeting on H.660 opened with legislative staff presenting a side-by-side of House and Senate versions of the bill that funds programs from the Opioid Abatement Special Fund.

Katie McLennan, Office of Legislative Council, told members the two versions largely match but contain five notable exceptions: differing dollar amounts for recovery residence and residential-treatment beds, an $800,000 recovery-center line that appears only in the Senate version, a $287,000 Senate appropriation to the Department of Public Safety for a public-safety enhancement team, and a $1.1 million Senate allocation intended for Burlington's Overdose Prevention Center (OPC) contingent on a site and operational readiness. "Here is the side by side," McLennan said, summarizing the differences and the sections involved.

Why it matters: committee members said the bill will determine how the special fund prioritizes treatment, recovery residences and harm-reduction activities statewide. Members pressed for clarity about funding sources, timing and whether awards should be treated as seed money or ongoing operations support.

On recovery beds, House negotiators proposed consolidating multiple line items into a single $1.2 million pool to give the Department of Health flexibility to fund NAR level-3 recovery residences and ASAM 3.1 residential treatment beds, with priority for unserved and underserved regions. "It allows [the department] to use that money flexibly in prioritizing unserved or underserved areas of the state," the Lawmaker representing the House said. The House and Senate had previously listed different dollar splits (for example, $600,000 vs. $900,000 on one line and $600,000 vs. $300,000 on another), and the consolidation is intended to preserve the total while easing distribution.

Members raised concern that special-fund awards could duplicate or conflict with Rural Health Transformation (RHT) grant distributions; the Department of Health was reported to have indicated the RHT program should not be jeopardized by these awards.

Pause on new FY28 proposals: both chambers agreed on language barring the settlement advisory committee from accepting new funding proposals from the special fund in fiscal year 2028 except for programs already statutorily intended for annual funding. Instead, the committee will review outcomes, effectiveness and sustainability of programs previously funded to inform recommendations for fiscal year 2029 and beyond. House members framed the restriction as a needed "pause" so the advisory process can mature and applicants understand awards may be seed funding rather than guaranteed ongoing support.

Contested Senate-only items: Senate negotiators told the committee they were cautious about immediately appropriating an additional $1.1 million to Burlington for an OPC because testimony showed the city's subcontractor had funding through FY27 and no lease or operational-ready site is yet identified. The Senate proposed a legislative-intent subsection that would allow appropriation "up to $1,100,000" for Burlington if the general assembly finds a location has been procured, the facility is fit up and will imminently become operational. The Lawmaker speaking for the Senate said the committee "did not seem wise" to appropriate additional FY27 funds for the OPC absent those conditions.

The Senate-only $287,000 for a Department of Public Safety harm-reduction program was discussed as well; one negotiating option offered was to fund that item by reducing the recovery-center line to $500,000 and reallocating the difference. "We are willing to consider that $287,000, but we would propose a reduction to recovery centers to $500,000 in order to fund that," the Lawmaker said. The House side said it would check budget availability.

Reporting and performance language: the Senate version includes quarterly Department of Health reports on special-fund expenditures for FY27 and would require a November plan on syringe-recovery models and the percentage of distributed syringes returned. Some committee members questioned the logic and feasibility of treating the returned-syringe percentage as a statewide performance metric, with one member saying measuring returned syringes "doesn't make any sense" because syringes come from many sources and disposal pathways vary.

Other technical changes discussed included clarifying that the advisory committee should consult the Attorney General's Office on allowable uses of the special fund and adding the Health Equity Advisory Commission to the stakeholder list. Members also discussed moving certain appropriation lines from the opioid-abatement fund into the substance-misuse prevention special fund — a difference between the chambers noted in McLennan's presentation.

No formal roll-call votes or final motions were recorded during this session; members agreed to continue off the floor, update Senator Benson and attempt to reconvene later the same day or early the next day to resolve remaining differences.

What happens next: staff will circulate draft edits reflecting the agreed language and the parties will attempt to meet again to finalize compromise language. The committee emphasized distinguishing seed/infrastructure funding from ongoing operational support in the bill language.

Sources: Committee discussion and the side-by-side presentation by Katie McLennan, Office of Legislative Council.